Tag: UroGen

Finance News

UroGen Pharma: ODAC Decision Puts Drug Approval In Limbo, But It's Not Over, Either

21/05/2025
admin

UroGen Pharma: ODAC Decision Puts Drug Approval In Limbo, But It's Not Over, Either #UroGen #Pharma…

Finance News

UroGen Pharma Ltd. (URGN) Q1 2025 Earnings Call Transcript

12/05/2025
admin

UroGen Pharma Ltd. (URGN) Q1 2025 Earnings Call Transcript #UroGen #Pharma #URGN #Earnings #Call #Transcript

Stock

UroGen Announces Updated 18-Month Duration of Response (DOR) of 80.6% from the Phase 3 ENVISION Trial of UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Inva

26/04/2025
admin

UroGen Announces Updated 18-Month Duration of Response (DOR) of 80.6% from the Phase 3 ENVISION Trial…

Finance News

UroGen: June 13 PDUFA For Potential Bladder Cancer Blockbuster Sets Up Strong Buy

12/04/2025
admin

UroGen: June 13 PDUFA For Potential Bladder Cancer Blockbuster Sets Up Strong Buy #UroGen #June #PDUFA…